I68.0 Cerebral amyloid angiopathy

Name of the Condition

• Cerebral Amyloid Angiopathy
• ICD-10 Code: I68.0

Summary

Cerebral amyloid angiopathy (CAA) is a condition characterized by the deposition of amyloid protein in the walls of small and medium-sized blood vessels in the brain. This accumulation can weaken vessel walls, leading to bleeding or other vascular complications. CAA is a common cause of lobar intracerebral hemorrhage in older adults and may contribute to cognitive decline.

Causes

CAA is primarily caused by the accumulation of amyloid-beta protein in cerebral blood vessels. The exact mechanisms triggering this deposition are not fully understood, but it is associated with aging and may involve genetic factors. The amyloid buildup disrupts the structural integrity of vessel walls, increasing the risk of hemorrhage or ischemia.

Risk Factors

• Advanced age (most common in adults over 65)
• History of hypertension
• Apolipoprotein E (APOE) ε2 or ε4 alleles (genetic predisposition)
• Prior cerebrovascular events
• Family history of CAA or related conditions

Symptoms

• Sudden headache (often severe)
• Neurological deficits (e.g., weakness, numbness, or speech difficulties)
• Cognitive impairment or dementia
• Seizures
• Visual disturbances
• Gait instability or balance problems

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging studies, and sometimes pathological confirmation. Magnetic resonance imaging (MRI) or computed tomography (CT) scans may reveal lobar hemorrhages or microbleeds. Cerebral angiography or magnetic resonance angiography (MRA) can assess vascular abnormalities. In some cases, brain biopsy may be performed to confirm amyloid deposition, though this is rarely necessary.

Treatment Options

Treatment focuses on managing symptoms and preventing complications. Acute hemorrhages may require supportive care, blood pressure control, or surgical intervention. Long-term management includes controlling hypertension, avoiding anticoagulants or antiplatelet drugs that increase bleeding risk, and addressing cognitive symptoms with appropriate therapies.

Prognosis and Follow-Up

Prognosis varies depending on the severity of bleeding or cognitive impairment. Recurrent hemorrhages are common, and some patients experience progressive cognitive decline. Regular follow-up with neurology or geriatrics is recommended to monitor for new symptoms, adjust medications, and address functional or cognitive changes.

Complications

• Recurrent intracerebral hemorrhage
• Dementia or cognitive decline
• Seizure disorders
• Hydrocephalus (rare)
• Increased risk of ischemic stroke

Lifestyle & Prevention

• Maintain blood pressure within target ranges
• Avoid medications that increase bleeding risk (e.g., aspirin, anticoagulants) unless medically necessary
• Engage in regular physical activity and a balanced diet to support vascular health
• Monitor for symptoms of cognitive decline and seek evaluation if changes occur

When to Seek Professional Help

Seek immediate medical attention for sudden severe headache, neurological symptoms (e.g., weakness, speech difficulty), or changes in consciousness. Follow up with a healthcare provider for persistent cognitive issues, balance problems, or unexplained mood changes.

Tips for Medical Coders

When coding for I68.0 (Cerebral amyloid angiopathy), ensure documentation supports the diagnosis, including clinical findings, imaging results, or pathological confirmation. Note any associated complications (e.g., hemorrhage, dementia) as they may require additional codes. Avoid coding for unrelated conditions or symptoms not directly linked to CAA.